Anti-FOLR1/FRA Antibody (Farletuzumab)
Catalog No.
F1002
Anti-FOLR1/FRA Antibody (Farletuzumab)
Featured Products
Farletuzumab (MORAb-003) is a potent folate receptor-α (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab has growth inhibitory effects on cells overexpressing FRα. Farletuzumab can be used in cancer research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.36 kDa
Dry ice
896723-44-7
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
MORAb-003, LK26
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P15328
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Cyno FRα HEK293 cells were stained with Anti-FOLR1/FRA Antibody (Farletuzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS
FOLR1 / FRA
Please avoid freeze-thaw cycles.